logo

For the Inventor, By the Inventor

Beijing, China

Xiangyang Chen

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Shanghai, CN (2018)
  • Beijing, CN (2019 - 2024)

Company Filing History:

goldMedal13 out of 14 
 
Beijing Innocare Pharma Tech Co., Ltd.
 patents
silverMedal6 out of 6 
 
Guangzhou Innocare Pharma Tech Co., Ltd.
 patents

Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 12448382 - Heterocyclic compounds for mediating tyrosine kinase 2 activity (2025-10-21),
2. 12391666 - Indoline-1-formamide compound, preparation method therefor, and medical use thereof (2025-08-19),
3. 12297188 - Crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamide (2025-05-13),
4. 12202813 - Process for preparing 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide (2025-01-21),
5. 12178808 - Amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide (2024-12-31),
6. 12162873 - Substituted nicotinimide inhibitors of BTK for treating cancer (2024-12-10),
7. 11945792 - Crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide (2024-04-02),
8. 11840513 - Substituted nicotinimide inhibitors of BTK for treating cancer (2023-12-12),
9. 11578058 - Heterocyclic compounds for inhibiting TYK2 activities (2023-02-14),
10. 11572353 - Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof (2023-02-07),
11. 11389445 - Pentafluorosulfanyl-substituted amide derivatives, preparation methods thereof and medical uses thereof (2022-07-19),
12. 11345695 - Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease (2022-05-31),
13. 11059805 - Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof (2021-07-13),
14. 11046682 - Fused heterocyclic derivatives, their preparation methods thereof and medical uses thereof (2021-06-29),
15. 10752631 - Heterocyclic compounds as FGFR inhibitors (2020-08-25),

Title: Xiangyang Chen - Pioneering Inventor from Beijing

Introduction: Xiangyang Chen is a distinguished inventor hailing from Beijing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xiangyang Chen holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his continuous commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Xiangyang Chen has worked with various leading tech companies and research institutions, where he has spearheaded numerous projects that have revolutionized the industry.

Collaborations: Throughout his career, Xiangyang Chen has collaborated with top researchers, engineers, and scientists from around the globe, fostering a culture of innovation and knowledge exchange that has led to remarkable advancements in the field.

Conclusion: Xiangyang Chen's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his position as a visionary inventor, inspiring the next generation of innovators to push the limits of what is possible in the world of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…